Further studies provided evidence that pharmacological inhibition of KCa3.1 channels by membrane-permeant drugs that can reach the mitochondria contributes to apoptosis in hepatocellular cancer HepG2 cells, malignant glioma cells [1, 25], as well as melanoma cells [3]. Here, KCNN4 is linked to melanoma.